| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| eisai and biogen's leqembi | 0.28 | 0.6 | 5392 | 98 | 26 |
| eisai | 0.78 | 0.2 | 118 | 33 | 5 |
| and | 0.52 | 0.7 | 5706 | 26 | 3 |
| biogen's | 0.77 | 0.2 | 6898 | 74 | 8 |
| leqembi | 1.05 | 0.6 | 3663 | 75 | 7 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| eisai and biogen's leqembi | 0.42 | 0.6 | 5615 | 16 |
| biogen/eisai | 0.94 | 0.3 | 7450 | 95 |
| eisai and biogen stock | 1.58 | 0.2 | 3033 | 21 |
| eisai patient support leqembi | 0.13 | 1 | 5931 | 68 |
| biogen eisai | 1.01 | 0.8 | 9985 | 52 |
| biogen eisai ole clarity | 1.33 | 0.6 | 7569 | 15 |
| biogen eisai lecanemab | 0.19 | 0.1 | 5375 | 16 |
| biogen eisai alzheimer's drug | 1.72 | 1 | 5786 | 99 |
| biogen eisai partnership | 1.03 | 1 | 2313 | 68 |
| biogen eisai announce lecanemab ole at ctad | 0.9 | 0.4 | 8104 | 37 |
| biogen eisai stock | 0.7 | 0.1 | 8489 | 21 |
| biogen eisai aducanumab | 1.11 | 0.5 | 7654 | 20 |
| biogen eisai partnership lecanemab | 1.89 | 0.9 | 3239 | 79 |
| eisai and biogen | 0.14 | 1 | 6579 | 31 |
| eisai biogen alzheimer | 1.48 | 0.8 | 7869 | 88 |
| eisai and biogen stock price | 0.67 | 0.2 | 9545 | 49 |
| eisai inc. and biogen | 0.68 | 0.1 | 5388 | 59 |
